ASHLEY LUTJEMEIER: Open Payments
NPI 1154779197 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $446
Food & beverage: $351Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $171 |
| Janssen Biotech, Inc. | 4 | $159 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Organogenesis Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
Products named: TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, ACTHAR, Rhapsido, SIMPLIMAX, Wegovy.
Industry payments across KS — which companies pay providers there.
